Halozyme’s Patent Win Over Merck Changes Future Deals
A Dutch court order restricting Keytruda SC in eight markets boosts Halozyme’s leverage.
A Dutch court order restricting Keytruda SC in eight markets boosts Halozyme’s leverage.
Volatility Shares won SEC approval for BITH and ETHK, but trading cannot start yet, and the entry price when it does will determine everything.
Autonomous and KBW see 10% to 15% property-cat rate cuts at Jan. 1 renewals, boosting primary insurers’ margins.
Open-source networking is moving into enterprises, and legacy vendors are responding in SEC filings.
Cannibalization fears are unresolved, a defined-risk call into earnings beats chasing the pop.
The NRC cleared TVA’s Clinch River reactor on Sept. 29. Here is what still stands between that milestone and actual electrons reaching a data center.
What it means if TSMC helps run a chip plant for Tesla, SpaceX, and xAI.
ISM services Monday, Fed minutes Wednesday, and PepsiCo Thursday tighten the October decision window into five days.
Credit desks price GPU collateral far below equities, and Broadcom’s $35 billion backstop shows what it costs to close the gap.
Five suppliers control 63-73% of the UQD coupling market. Here is who holds the keys.